Breast cancer researcher to receive lecture award at SABCS
Click Here to Manage Email Alerts
Laura J. van ’t Veer, PhD, will receive the William L. McGuire Memorial Lecture Award at this year’s San Antonio Breast Cancer Symposium, scheduled for Dec. 10-13.
The award recognizes van ’t Veer for her work advancing risk stratification, subtyping and improved treatment for early breast cancer.
“Dr. van ’t Veer fully epitomizes the spirit and legacy of this award in honor of Dr. McGuire, starting from basic science discovery to translational and clinical research to standard of care for the benefit of patients worldwide,” Carlos Arteaga, MD, FAACR, director of the Simmons Comprehensive Cancer Center and associate dean of oncology at UT Southwestern Medical Center, as well as SABCS co-director, said in a press release.
Van ’t Veer is professor and Angela and Shu Kai Chan endowed chair in cancer research in the department of laboratory medicine at University of California, San Francisco.
She also is director of applied genomics and leader of the breast oncology program at UCSF Helen Diller Family Comprehensive Cancer Center.
Van ’t Veer’s research focuses on personalized medicine, with the goal to advance patient management based on deeper understanding of each tumor’s genetic makeup.
She developed MammaPrint (Agendia), a test that helps predict the likelihood that breast cancer will come back or metastasize. She also built the scientific platform used in the I-SPY 2 trial, an adaptive trial designed to evaluate new drugs for neoadjuvant treatment of high-risk breast cancer.
“I’m very honored to have been selected to receive the 2024 award. Individualizing breast cancer treatment was the passion of William McGuire, as it is mine,” van ’t Veer said in the release. “I’m super excited that our biomarker discoveries predicting which patients benefit from chemotherapy — and what targeted therapy, including immunotherapy, further improves their outcomes — have found their way to standard of care and into clinical trials. Avoiding unnecessary treatment and avoiding side effects can be as important as finding the treatment that works for each individual patient.”
Collapse
Press Release
Read more about
Click Here to Manage Email Alerts